These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28408778)

  • 21. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs.
    Cano JP; Dee SA; Murtaugh MP; Trincado CA; Pijoan CB
    Am J Vet Res; 2007 May; 68(5):565-71. PubMed ID: 17472459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model.
    Pileri E; Gibert E; Martín-Valls GE; Nofrarias M; López-Soria S; Martín M; Díaz I; Darwich L; Mateu E
    Vet Microbiol; 2017 Mar; 201():18-25. PubMed ID: 28284607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
    Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
    Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
    Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
    J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
    Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
    Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine.
    Piras F; Bollard S; Laval F; Joisel F; Reynaud G; Charreyre C; Andreoni C; Juillard V
    Viral Immunol; 2005; 18(2):381-9. PubMed ID: 16035950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
    Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal localization of porcine reproductive and respiratory syndrome virus in reproductive tissues of experimentally infected boars.
    Prieto C; García C; Simarro I; Castro JM
    Theriogenology; 2003 Nov; 60(8):1505-14. PubMed ID: 14519471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of porcine reproductive and respiratory syndrome virus in semen and tissues from vasectomized and nonvasectomized boars.
    Christopher-Hennings J; Nelson EA; Nelson JK; Rossow KD; Shivers JL; Yaeger MJ; Chase CC; Garduno RA; Collins JE; Benfield DA
    Vet Pathol; 1998 Jul; 35(4):260-7. PubMed ID: 9684969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of U.S., Lelystad, and European-like porcine reproductive and respiratory syndrome viruses and relative quantitation in boar semen and serum samples by real-time PCR.
    Wasilk A; Callahan JD; Christopher-Hennings J; Gay TA; Fang Y; Dammen M; Reos ME; Torremorell M; Polson D; Mellencamp M; Nelson E; Nelson WM
    J Clin Microbiol; 2004 Oct; 42(10):4453-61. PubMed ID: 15472293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
    Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
    J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.
    Savard C; Alvarez F; Provost C; Chorfi Y; D'Allaire S; Benoit-Biancamano MO; Gagnon CA
    Can J Vet Res; 2016 Jan; 80(1):1-11. PubMed ID: 26732457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for infection of sow herds with porcine reproductive and respiratory syndrome (PRRS) virus.
    Mortensen S; Stryhn H; Søgaard R; Boklund A; Stärk KD; Christensen J; Willeberg P
    Prev Vet Med; 2002 Feb; 53(1-2):83-101. PubMed ID: 11821139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
    Cano JP; Dee SA; Murtaugh MP; Pijoan C
    Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.